Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion type Assertion NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_head.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion description "[These results may provide a basis of developing improved chemotherapy regimens, including or excluding glucocorticoid receptor agonists/antagonists, for urothelial carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion evidence source_evidence_literature NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion SIO_000772 23033490 NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion wasDerivedFrom befree-2016 NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.
- NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_assertion wasGeneratedBy ECO_0000203 NP1017861.RA48XBot1Ggq9WAivC0ly6oOwloDUyc4IOQJPdrmw0lFw130_provenance.